SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

EKTAB (EKTAB) News

Follow EKTAB (EKTAB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol EKTAB Asset market Sector Markets 90 days 11 Updated Sep 29, 2026, 07:01 PM UTC Open live news feed
L Elekta (EKTA_B) Posts Phase 2 Data Supporting Gamma Knife Cognitive Outcomes Elekta announced phase 2 data from Sunnybrook showing favorable memory performance 2 months after Leksell Gamma Knife radiosurgery in patients with 5—50 brain metastases, with no difference in time to meaningful cognitiv NEWS | Sep 29, 2026, 07:01 PM UTC L Elekta (EKTA_B) Reports Positive MR-Linac Data in Pancreatic Cancer Elekta said an MSK study of 123 patients treated on Elekta Unity showed 2-year overall survival of 37.4% and 3-year of 26.3%, with 76.8% local control at 2—3 years after high-dose adaptive radiotherapy.Material DetailsCo NEWS | Sep 28, 2026, 05:00 PM UTC L Elekta (EKTA_B) Expands Adaptive Radiotherapy Portfolio Elekta broadened adaptive workflows across CT- and MR-guided radiotherapy, radiosurgery and prostate brachytherapy, adding online adaptive for Harmony and introducing Prostate Guideway, pending FDA 510(k) and CE marking REGULATION | Sep 27, 2026, 03:40 PM UTC L Elekta holds Annual General Meeting on September 3, 2026 Elekta AB held its Annual General Meeting on September 3, 2026. CEO and President remarks and documents covering all resolutions are available on the company website. EQUITY | Sep 03, 2026, 02:20 PM UTC L EKTA_B Q1 margin expansion, cash flow improve; sales and EBIT guidance reaffirmed Q1 showed margin expansion and improved cash flow. Sales and EBIT margin guidance was reaffirmed. EARNINGS | Aug 27, 2026, 10:26 AM UTC L EKTA_B: Q1 margins rose; Q2 sales growth expected to rebound Q1 results showed higher margins and cost savings. EKTA_B expects sales growth to rebound in Q2. EARNINGS | Aug 27, 2026, 09:33 AM UTC L EKTA_B: Profitability and margins improved, with order growth and reiterated positive outlook for FY26/27 EKTA_B: Profitability and margins improved, with order growth and reiterated positive outlook for FY26/27 EQUITY | Aug 27, 2026, 07:28 AM UTC L Sweden's Elekta Q1 sales fall 3% on China market weakness Sweden's Elekta Q1 sales fall 3% on China market weakness GEOPOLITICS | Aug 27, 2026, 05:40 AM UTC L Elekta Q1 adjusted EBIT SEK 395 million, above consensus Elekta reported Q1 adjusted EBIT of SEK 395 million, above company consensus. EARNINGS | Aug 27, 2026, 05:39 AM UTC L EKTA_B: Profitability surged with higher margins and net income, while order intake supports future growth EKTA_B: Profitability surged with higher margins and net income, while order intake supports future growth EQUITY | Aug 27, 2026, 05:32 AM UTC L First quarter, May—July 2026/27 First quarter, May—July 2026/27 EQUITY | Aug 27, 2026, 05:30 AM UTC